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| INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease, which is characterized by a progressive airflow obstruction along with abnormal inflammatory responses (bronchiolitis) and alveolar destruction (emphysema). 1 Cigarette smoking (CS) is the main aetiological factor for the development of COPD. CS contains various toxic chemicals including reactive aldehydes, quinones and semiquinones in puff. 2 CS also causes endogenous reactive oxygen species release from recruited macrophages and neutrophils, which further induces inflammatory responses and subsequent lung injury.
Therefore, the modulation for redox balance plays pivot roles in regulating inflammatory response, which could be therapeutic targets for COPD/emphysema treatment. However, there is still lack of full understanding of molecular mechanisms underlying abnormal inflammatory responses in COPD.
Wnt/b-catenin is an evolutionarily conserved cellular signalling system that involves in embryonic development, homoeostatic selfrenewal and pathogenesis of human diseases. 3 In shown to increase proliferation of lung epithelial cells during lung epithelial injury and repair. 4 Furthermore, Wnt3a activation can inhibit neutrophils influx into the alveolar airspace of injured lungs as well as experimental emphysema. 5 However, the molecular mechanisms underlying the protection of Wnt signal against COPD are unknown.
Nuclear factor erythroid-2-related factor-2 (Nrf2) is a master transcription factor, which protects against oxidative stress by inducing the expression of anti-oxidative genes including NQO1 and HO-1. It is well-known that Nrf2 protects against the development of emphysema in rodents. [6] [7] [8] [9] A recent study demonstrates that Wnt3a stabilizes Nrf2 by preventing its GSK-3-dependent phosphorylation and degradation in hepatocytes. 10 Furthermore, AMP-activated protein kinase (AMPK) has been shown to activate Nrf2, which links to GSK-3b inhibition. 11, 12 However, it is unknown whether Nrf2 mediates the protection of Wnt3a and AMPK against pulmonary emphysema. We hypothesize that Wnt3a/b-catenin and AMPK co-regulate Nrf2, thereby modulating lung inflammatory and injurious responses during the development of COPD/emphysema.
| MATERIALS AND METHODS

| Mice and drug administration
Nrf2 À/À mice with C57BL/6J background were kindly provided by the Jiangsu Province Institute of Traditional Chinese Medicine, Nanjing, China, which were originally purchased from the Jackson Laboratory, USA (Order number:3363093). These mice were bred by crossing Nrf2 À/À and C57BL/6J wild-type (WT) mice, and maintained with free access to water and food in the laboratory of the 
| Immunofluorescence
The cells were fixed with 4% paraformaldehyde for 20 minutes and then washed with PBS and permeabilization with 0.1% Triton 9100. 
| Statistical analysis
All the relevant data are expressed as mean AE SD. One-way ANOVA following LSD test or Dunnett's T3 test were performed for multiple comparisons. The statistical analyses were conducted using the SPSS 13.0 software, and the values of P < .05 were considered to be statistically significant. mice. Lung tissues from mice were subjected to Western blot for determining b-catenin, Nrf2, HO-1, NQO1 and IL-6 levels. There presentative bands were obtained from different gels for repeated experiments. After densitometry, the values of proteins were normalized against b-actin. Data were shown as mean AE SD (n = 3-4 per group). **P < .01, vs the corresponding saline groups; # P < .05, ## P < .01, vs the corresponding PPE-exposed groups F I G U R E 3 Wnt activation decreased IL-6 and KC levels in lung BAL fluid and homogenates in mice intratracheally injected with CSE. Lung BAL fluid and homogenates were used for IL-6 and KC detection by ELISA. Mice were intratracheally injected with CSE (20%, 100 lL) followed by LiCl treatment (ip, 200 mg/kg/bw/day). Lung BAL fluid (A) and homogenate (B) were used to detect IL-6 and KC by ELISA. Histogram bars represent meansAE SD (n = 3-4 per group). **P < .01, vs the corresponding saline groups; ## P < .01, vs the corresponding CSE-exposed groups CUI ET AL. 3.4 | Wnt3a increased the Nrf2 activation and decreased IL-6 levels in NHBE cells exposed to CSE
First, we assessed cell viability by MTT assay in response to various concentrations of CSE (0%-4%) for 24 and 48 hours. Treatment with CSE higher than 1% significantly decreased cell viability in NHBE cells (Figure S1A) . Hence, we investigated the effects of CSE (0, 0.25%, 0.5%, 1%)
on the Wnt/b-catenin and Nrf2 pathway proteins at 24 and 48 hours by
Western blot. As shown in Figure S1B and C, the levels of Wnt3a, b- Figure 4A ). As shown in Figure 4B , treatment with rhWnt3a (25 ng/mL) for 24 hours increased not only Wnt3a/b-catenin but also Nrf2, HO-1 and NQO1 levels by CSE treatment (1%) in NHBE cells. CSE-induced increase in IL-6 was significantly reduced by rhWnt3a
(25 ng/mL). Immunofluorescence also showed the increasing nuclear translocation of Nrf2 after rhWnt3a treatment ( Figure 4C ). Furthermore, the responses observed in Figure 4B were reversed by Wnt3a siRNA transfection ( Figure 4D ). Nrf2 siRNA further increased IL-6 levels by F I G U R E 5 Wnt3a activation decreased IL-6 level via Nrf2 in NHBE cells exposed to CSE. A, Nrf2 siRNA were transfected into NHBE cells for 6 h; then, the rhWnt3a (25 ng/mL) was added to cells for 24 h before treated with CSE (1%) for 48 h. Related proteins of Wnt/b-catenin and Nrf2 pathways: Wnt3a, b-catenin, Nrf2, HO-1, NQO1 and IL-6 were detected by Western blot. There presentative bands were from different gels for repeated experiments. After densitometry analysis, the values of proteins were normalized against b-actin. B, Nrf2 siRNA were transfected into NHBE cells for 6 h; then, the LiCl (10 mmol/L, 24 h) was added to cells for 24 h before treated with CSE (1%) for 48 h. Level of pro-inflammatory cytokines including IL-6 and IL-8 in cell supernatants was measured by ELISA. Data were shown as mean AE SD (n = 3-4 per group). **P < .01, vs the corresponding control groups; # P < .05, ## P < .01, vs the corresponding CSE+Wnt3a or CSE+LiCl group CUI ET AL.
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CSE. However, Nrf2 siRNA transfection had no effects on Wnt3a or bcatenin protein in NHBE cells regardless of CSE exposure ( Figure S2 ).
Altogether, these findings further support the notion that Wnt3a
activates Nrf2-dependent signals but reduces IL-6 levels in NHBE cells exposed to CSE, and Nrf2 protects against CS-induced lung inflammatory responses but does not affect Wnt3a.
F I G U R E 6 AMPK reduction in lungs of PPE-induced emphysematous mice, and AMPK increased p-Nrf2 level in NHBE cells exposed to CSE. A, Mice were subjected to PPE (80 U/kg, endotracheal injection). Lung tissues from mouse were subjected to Western blot analysis for AMPK, p-AMPK. B, NHBE cells were treated with different concentrations of metformin (0, 0.1, 0.2, 0.4, 0.8, 1.6 mmol/L) for 24 h. C, Metformin (0.8 mmol/L) was given to NHBE cells for 24 h before treated with CSE (1%) for 48 h. Related proteins: p-AMPK, p-Nrf2, HO-1 and b-catenin were detected by Western blot. Presentative bands were obtained from different gels for repeated experiments. Data were shown as mean AESD (n = 3-4 per group). **P < .01, vs the corresponding control groups; # P < .05, ## P < .01, vs the corresponding CSE-exposed groups F I G U R E 7 Metformin decreased IL-6 and IL-8 levels via Nrf2 in NHBE cells exposed to CSE. Nrf2 siRNA were transfected into NHBE cells for 6 h, and then, metformin (0.8 mmol/L) was added to cells for 24 h before treated with CSE (1%) for 48 h. Level of pro-inflammatory cytokines IL-6 and IL-8 in cell supernatants were measured by ELISA. Data were shown as meanAESD (n = 3-4 per group). **P < .01, vs the corresponding control groups; ## P < .01, vs the corresponding CSE+Metformin group 3.7 | Metformin decreased IL-6 and KC levels in lung BAL fluid and homogenates in mice intratracheally injected with CSE
Although we have shown that AMPK attenuates PPE-induced emphysema, 19 it remains elusive whether metformin decreases
Metformin decreased IL-6 and KC levels in lung BAL fluid and homogenates in mice intratracheally injected with CSE. Lung BAL fluid (A) and homogenates (B) were used for detecting IL-6 and KC by ELISA. Mice were intratracheally injected with CSE (20%, 100 lL) followed by metformin treatment (250 mg/kg, oral gavage). Histogram bars represent meansAESD (n = 3-4per group). **P < .01, vs the corresponding saline groups; ## P < .01, vs the corresponding CSE-exposed groups
CS-induced inflammatory response in mouse lungs. We administered metformin (250 mg/kg, oral gavage) to C57BL/6J mice 2 hours before intratracheal injection of CSE (20%, 100 lL) daily for 3 days.
We found that metformin significantly reduced CSE-induced increase in IL-6 and KC levels in BAL fluid and homogenates in mice (Figure 8) . These results suggest that AMPK activation reduces lung inflammatory responses to CS.
| Metformin increased the Nrf2 activation via
Wnt3a/b-catenin pathway in NHBE cells exposed to CSE
To further determine the relationship between AMPK and Wnt3a/bcatenin pathways to the effect of Nrf2 activation, we treated metformin (0.8 mmol/L) for 24 hours in CSE-exposed NHBE cells. These results showed that metformin significantly increased Wnt3a and b-catenin levels ( Figure 9A ). However, the effects of metformin on In addition to Keap1, Nrf2 can be subjected to SCF/b-TrCPdependent ubiquitination and proteasomal degradation in a GSK3b-dependent but b-catenin-independent manner. 10,22 GSK-3b is one of the b-catenin destruction complexes in Wnt pathway as the previously described. 5, 23 Although Wnt/b-catenin pathway has been shown to protect against the development of COPD/emphysema, 5, 24 it remains unknown whether these protective effects are mediated CS exposure only reproduces the mild aspects of emphysema but requires 4-6 months of duration. 41 Therefore, we utilized the elastase-induced emphysema model, where lung injury develops rapidly and severely. This is relatively easy (one time injection) and cheap (do not need smoke machine/facility) to assess the effects of LiCl on the development of emphysema. 26 Nevertheless, future stud- 
